The Deeply Human Core Of Roche's $2.1 Billion Tech Acquisition -- And Why It Made It
Flatiron’s key insight was that, in cancer, at least half of the most important data in health records isn’t in structured data fields but rather in unstructured data, the free text fields of pathology reports and clinical notes, and extracting this information (at least today) requires people.
Innovation Healthcare The Deeply Human Core Of Roche's $2.1 Billion Tech Acquisition -- And Why It Made It By David Shaywitz , Former Contributor. Feb 18, 2018, 11:32am EST Feb 20, 2018, 05:10pm EST This article is more than 8 years old. Flatiron cofounder Nat Turner was on the FORBES 30 Under 30 list for healthcare in 2015, when he was 28. Walter Smith for Forbes Roche's recently announced acquisition of the oncology data company Flatiron Health for $2.1 billion represents a robust validation of the much-discussed but infrequently realized hypothesis that technology entrepreneurs who can turn
Explore this link on the map →related reading
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Biotech’s Lost Archive | IFPifp.org
- State of Data (Jan 2026)seancai.com
- How Health Data Gets Sold: Moving From Third-Party to First-Party | Out-Of-Pocketoutofpocket.health
- Paving the way for agents in biology \ Anthropicanthropic.com
- Payvidors, Unbundled: Opportunities in Healthcare Fintech | Andreessen Horowitza16z.com
- The Great Data Integration Schlep — LessWronglesswrong.com
- Hey Tech, It's Time To Build. In Healthcare. | Andreessen Horowitza16z.com
- Biotech’s Lost Archive | IFPifp.org
- What I Learned From The Modern Data Stack Conference 2021 - James Lejameskle.com
- Putting Data in a Corner: LLMs and Financial Services Data | Andreessen Horowitza16z.com
- From a ‘deranged’ provocateur to IBM’s failed AI superproject: the controversial story of how data has transformed healthcaretheconversation.com